Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

RLAY

Relay Therapeutics (RLAY)

Relay Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RLAY
DateTimeSourceHeadlineSymbolCompany
06/06/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RLAYRelay Therapeutics Inc
06/06/202421:00GlobeNewswire Inc.Relay Therapeutics Discloses Three New Programs at New Program & Platform EventNASDAQ:RLAYRelay Therapeutics Inc
06/06/202410:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLAYRelay Therapeutics Inc
06/06/202410:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLAYRelay Therapeutics Inc
06/06/202410:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLAYRelay Therapeutics Inc
06/06/202410:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLAYRelay Therapeutics Inc
06/06/202406:12Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RLAYRelay Therapeutics Inc
06/06/202406:05GlobeNewswire Inc.Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608NASDAQ:RLAYRelay Therapeutics Inc
05/06/202406:07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RLAYRelay Therapeutics Inc
04/06/202406:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RLAYRelay Therapeutics Inc
22/05/202406:05GlobeNewswire Inc.Relay Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:RLAYRelay Therapeutics Inc
13/05/202422:30GlobeNewswire Inc.Relay Therapeutics to Host New Program and Platform Event on June 6, 2024NASDAQ:RLAYRelay Therapeutics Inc
03/05/202406:05GlobeNewswire Inc.Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate HighlightsNASDAQ:RLAYRelay Therapeutics Inc
26/04/202406:05GlobeNewswire Inc.Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024NASDAQ:RLAYRelay Therapeutics Inc
12/04/202406:05GlobeNewswire Inc.Relay Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:RLAYRelay Therapeutics Inc
27/02/202408:05GlobeNewswire Inc.Relay Therapeutics to Participate in Three Upcoming Investor ConferencesNASDAQ:RLAYRelay Therapeutics Inc
23/02/202408:34Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:RLAYRelay Therapeutics Inc
23/02/202408:16Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:RLAYRelay Therapeutics Inc
23/02/202408:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RLAYRelay Therapeutics Inc
23/02/202408:05GlobeNewswire Inc.Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate HighlightsNASDAQ:RLAYRelay Therapeutics Inc
16/02/202408:05GlobeNewswire Inc.Relay Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights on February 22, 2024NASDAQ:RLAYRelay Therapeutics Inc
02/02/202408:05GlobeNewswire Inc.Relay Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceNASDAQ:RLAYRelay Therapeutics Inc
01/02/202408:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLAYRelay Therapeutics Inc
01/02/202408:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLAYRelay Therapeutics Inc
19/01/202408:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLAYRelay Therapeutics Inc
19/01/202408:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLAYRelay Therapeutics Inc
19/01/202408:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLAYRelay Therapeutics Inc
11/01/202401:22Edgar (US Regulatory)Form 424B7 - Prospectus [Rule 424(b)(7)]NASDAQ:RLAYRelay Therapeutics Inc
11/01/202401:14Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:RLAYRelay Therapeutics Inc
08/01/202423:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RLAYRelay Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:RLAY